Hyperbaric Oxygenation in the Treatment of Traumatic Brain Injury by Beckman, Robert Louis
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







Hyperbaric Oxygenation in the 




Hyperbaric Oxygen Therapy can help heal brain wounds: TBI/PTSD/Concussion. 
Peer-reviewed positive scientific and clinical evidence in over 7500 cases demonstrates 
that HBOT helps heal wounded brains and returns patients to a life denied them by 
DOD/VA/Army that will not talk about, or even use or pay for HBOT treatment for 
TBI/PTSD/PCS/Concussion. Successful treatment with HBOT [40 one-hour  sessions] 
virtually eliminates suicidal ideation, an effective “suicide prevention” method. 
Patients also reduce their drug intake to nearly zero and experience 50% reduction in 
pain and time to withdrawal. The history of HBOT for TBI is littered with bad  science, 
but evidence-based and clinical medicine data show the safety, efficacy and cost 
effectiveness of HBOT as a standard of care that should be put on-label and insured.
Keywords: hyperbaric oxygen, TBI, PTSD, concussion
“The truth goes through three stages: first, it is ridiculed, then it is violently 
opposed, and then, it is accepted as self-evident.”
Arthur Schopenhauer
"First they ignore you, then they laugh at you, then they fight you, then you win." 
Mahatma Gandhi
1. Introduction
Though neither of these quotes is quite true, they lead this introduction because 
those who are working to heal broken brains and stop the suicide epidemic are 
closer to winning than when they started. There are no guarantees that collective 
successes will overcome medical resistance to accepting the obvious: what “they” 
are doing does not work to heal brain wounds, and “they” ignore and denigrate 
a safe and effective treatment that does. Yet those trying to get urgent help to 
suicidal brain wounded service members see victory on the near horizon for the 
varieties of truths told in the research and worldwide clinical medicine. As with 
many advances, an anecdote helps elucidate the main point: changing minds and 
 medicine, even with science, data and facts, is not easy work.
Two renegade Australian MDs, Barry Marshall and J. Robin Warren, in 1981 
knew there was a simple treatment for gastritis and peptic ulcers: an antibiotic to kill 
Heliobacter pylori bacteria. Now, Helicobacter pylori may be the most  successful 
pathogen in human history. While not as deadly as the bacteria that cause tuberculosis, 
Advancement and New Understanding in Brain Injury
2
cholera, and the plague, it infects more people than all the others  combined. Yet 
conventional medicine already knew that ulcers were caused by stress. An entire set 
of industries grew up around “healing” stress and its aftermath: antacids, stomach 
surgery for bleeding ulcers, gastritis, stomach cancer, depression. “To gastroenterolo-
gists, the concept of a germ causing ulcers was like saying that the Earth is flat.” [1] 
To them, the cause of all the illness and death was psychosomatic, “all in the head.” 
Marshall went so far to prove his point that he gave himself ulcers by drinking a broth 
of H.pylori and curing himself. And still not recognition. Cut to the chase: For their 
relentless persistence and science on H.pylori, in 2005 Marshall and Warren won the 
Nobel Prize. Treatment with an antibiotic is standard medicine for stomach cancer [2]. 
Twenty-four years to go from goats to Nobel  laureates. Along the way, the men were 
ridiculed and denounced by learned  councils around the world. And then the “truth.”
As you read these pages, we expect that you will be whipsawed by the truths 
exposed as authors and readers wonder about the answer to the Obvious Question: 
Since this works, why are they opposed to it? As you will see, there are no complete 
answers, but the data and the peer-reviewed research do provide compelling and 
overwhelming evidence of the safety, efficacy, and cost-effectiveness of this treat-
ment. Over 7500 successes cannot be entirely wrong.
2. Background
On August 30, 2002, Medicare announced its intention to issue a national 
 coverage determination (NCD) for Hyperbaric Oxygen Therapy (HBOT) in the 
treatment of diabetic wounds of the lower extremities. The arguments that led 
to that determination [3] established that oxygen under pressure was safe and 
 effective for this fourteenth indication, or disease state.
The evolution in thinking and the subsequent research was enabled by the 1999 
refinement and restatement of the drug definition of HBOT as the use of greater 
than atmospheric pressure oxygen as a drug to treat basic pathophysiologic processes 
and their diseases [4]. The UHMS defines hyperbaric oxygen (HBO2) as an interven-
tion in which an individual breathes near 100% oxygen intermittently while inside 
a hyperbaric chamber that is pressurized to greater than sea level pressure (1 atmo-
sphere absolute, or ATA) [5]. With that definition the totality of on-label indications 
could be understood as cohesive sets of diagnoses connected by HBOT effects on the 
acute and/or chronic underlying pathophysiology common to the diseases.
Doctors noticed that the definition necessarily could be applied to the use of 
HBOT for additional diseases that shared this pathology. Of the 14/15 indications 
accepted by the FDA/CMS, at least five are non-healing wounds and therefore 
closely related to brain wounding from blast, falls, impact, stroke, Improvised 
explosive devices, and concussion. Those indications are: Crush injury, compart-
ment syndrome, and other acute traumatic ischemias; Arterial Insufficiency, 
entailing enhancement of healing in selected problem wounds (includes uses like 
Diabetic Foot Wounds, Hypoxic Wounds); Radiation tissue damage (soft tissue 
and bony necrosis); Skin grafts and flaps (compromised); and Air or gas embolism 
(resulting from rapid decompression and blast injury [6].)
The accurate drug definition of HBOT, and its implications for the findings and 
data in research into traumatic brain injury, is used in this paper to argue for HBOT 
safety and effectiveness in the treatment of Traumatic Brain Injury. The argument 
is constructed by identifying the underlying pathophysiology in traumatic brain 
injury. Evidence for the beneficial effects of HBOT on TBI is presented. Benefits to 
patients with TBI is discussed. Evidence for HBOT for TBI risk/benefit and cost/are 
discussed. The conclusion is simple: coverage of HBOT for TBI.
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3. Traumatic brain injury basics
Research over the last two decades has revealed the complex microcosms of 
multiple pathophysiological processes resulting from insults to the brain, includ-
ing traumatic brain injury [7]. The three essential components determining the 
outcome of head injuries are brain blood flow; the pressure in the skull leading to 
swelling; and hypoxia, the lack of oxygen [8].
According to the Centers for Disease Control and Prevention (CDC), “traumatic 
brain injury (TBI) is caused by a bump, blow or jolt to the head or a penetrating 
head injury that disrupts the normal function of the brain.” TBI severity ranges 
from “mild,” i.e., a brief change in mental status or consciousness to “severe,” i.e., an 
extended period of unconsciousness or amnesia after the injury [9]. The CDC keeps 
current statistics on TBI death and disability.
Traumatic brain injury (TBI) is a major cause of death and disability in the 
United States. Those who survive a TBI can face effects that last a few days, or 
the rest of their lives. Among TBI-related ED visits and hospitalizations in 2014, 
statistics notable for the CDC include:
• Hospitalization rates were highest among persons 75 years of age and older
• The highest rates of ED visits included persons 75 years of age and older
• For adults 55 years of age and older, falls were the leading cause of hospitaliza-
tions and ED visits
• Among TBI-related deaths in 2014, rates were highest for persons 75 years of 
age and older
• In 2014, an average of 155 people in the United States died each day from 
injuries that include a TBI
• Between 2001 and 2010, the estimated average annual numbers of TBI in the 
US equaled: TBI contributed to the deaths of 56,800 people; 282,000 hospital-
izations; and 2.5 M ER visits.
• Accidental traumatic brain injuries contributed to more deaths than suicides 
and homicides together [10].
• Approximately 5.3 M people in the US live with a permanent TBI [11]
• The lifetime economic cost of TBI, including direct and indirect medical costs, 
was estimated to be approximately $76.5 billion (in 2010 dollars) [12].
• Current estimates put the yearly costs of TBI among veterans at $48 billion [13].
UCLA researchers, citing animal and human studies, speak of “a neurometabolic 
cascade of events that involves bioenergetic challenges, cytoskeletal and axonal 
alterations, impairments in neurotransmission and vulnerability to delayed cell 
death and chronic dysfunction.. .. linking the neurometabolic cascade to clinical 
characteristics as well as on new connections being made between acute post- 
concussion pathophysiology, long-term biological changes and chronic sequelae.” 
[14] Further: “The etiology of postconcussive syndrome is debated, but may be 
caused by diffuse axonal injury or persistent metabolic alterations resulting in 
neuronal dysfunction and develops in 38–80% of patients with TBI….” [15].
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Advanced neuroimaging reveals the basic neurobiology of concussion/mild 
TBI in animal models, which is increasingly corroborated in human studies. These 
images of the brain with such techniques as diffusion tensor imaging (DTI) validate 
the wounding from the brain injury.
Since HBOT has been studied as a science for over 84 years [16], a wealth of 
evidence exists - with or without brain imaging or functional imaging such as 
SPECT scans - that points to the wounding of the brain as an underlying cause of 
TBI and, in many cases, the cooccurrence of Post-traumatic stress disorder (PTSD). 
Controversy continues to wage over proper diagnoses of TBI and PTSD. The author 
is aware for over a decade of clinical medicine and the accumulation of “anecdotal 
evidence” in over 7500 successful uses of HBOT to help treat and heal TBI, that 
those combat veterans presenting with “PTSD only” diagnoses from the VA are 
overwhelmingly afflicted with undiagnosed TBI. Researchers have not yet fully 
understood how TBI commonly affects the neurological and clinical presentation of 
PTSD [17]. Despite this high prevalence, the pathogenesis of TBI, PTSD and TBI/
PTSD remains largely unknown, hindering prevention and treatment efforts [18].
No matter how acquired, TBI in a veteran or a civilian, is an injury to the brain 
tissue. Damage is physiological, behavioral, and emotional. Symptoms can include 
altered consciousness; headaches; structural damage to brain matter and blood 
vessels and nerves; loss of neurological function that can lead to loss of motor, 
sensory, coordination, balance, vision, hearing and other abilities; inability to 
multi-task, slowed reaction time, decreased attention and concentration, inability 
to think fast; and frequent incapacity to work, sleep, relax, think or discern what is 
normal. When wounded, the brain, like all body organs, responds with the inflam-
matory process which proceeds to form scars, scar tissue, and chronic wounds. 
When the brain injury is compounded by post traumatic stress disorder (PTSD) the 
victim is subjected to hyperarousal, avoidance behaviors, trauma re-experiencing, 
increased mental vigilance, difficulty falling asleep, nightmares, constant anxiety 
resulting from progressive sleep deprivation and elevation of injurious stress hor-
mones. Behaviors and emotions are magnified, intensifying the patient’s negative 
responses: relationship problems, domestic violence, substance abuse, depression, 
criminal activity, unemployment, incarceration, homelessness, and too frequently 
suicide. Where the degenerative cycle can be arrested with drugs or psychological 
interventions, the result may be a lifetime of degraded quality of life on welfare – 
not only for the patient but typically for the caregiver as well.
In 2016, researchers at the Uniformed Services University of the Health Sciences 
in Bethesda, Md., found evidence of tissue damage caused by blasts alone, not by 
concussions or other injuries [19]. According to the New York Times, this could be 
the medical explanation for shell shock and the sequalae of psychological prob-
lems called PTSD [20]. The implications are clear: IEDs, breeching, enemy and/or 
friendly fire from personal weapons can lead directly to physical brain damage and 
the accompanying effects, many of which are diagnosed as “only PTSD.”
Not to be overlooked are the complex interactions among brain injury, trauma, 
and physical/emotional/behavior/mental health. Psychiatrist Bessel van der Kolk, 
in The Body Keeps the Score [21], explains how trauma and its resulting stress harms 
us through physiological changes to body and brain, and that those harms can 
persist throughout life. Stress, trauma, depression, mental and physical health are 
so intertwined that it is hard to know the seat of the disease. The author argues that 
trauma is one of the West’s most urgent public health issues. The list of its effects is 
long: on mental and physical health, employment, education, crime, relationships, 
domestic or family abuse, alcoholism, drug addiction. As with PTSD and TBI, 
whether a brain insult precedes mental health problems, it is certain that the brain 
and the body will suffer in time.
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Several studies have looked at this downward cycle in untreated brain injuries 
[22] and noted a correspondence between the symptoms resulting from that 
brain injury and the HBOT Mechanisms of Action that work to arrest and heal the 
traumatic brain injury.
4. Hyperbaric oxygenation mechanisms of action
Medical studies have shown that Hyperbaric Oxygen Therapy is medicine’s best 
way to provide oxygen to all parts of the body in the shortest period of time. Among 
many effects, HBOT has been shown to be effective in:
• Reducing local swelling (edema) and reperfusion injury
• Promoting wound healing
• Improving and repairing injury, by increasing oxygen delivery to damaged 
tissues
• Improving infection control
• Releasing nitric oxide with migration to point of injury
• Increasing the production of collagen
• Releasing stem cells with migration to area of injury
• Improving blood flow to the affected area of the brain
• Restarting stunned cellular metabolism and stunned mitochondria
• Generating blood vessel growth (angiogenesis)
• Activating stem cells 8x normal to repair neural pathways (neurogenesis)
• Decreasing markers of inflammation in the body and brain [23]
While it is uncommon to hear HBOT talked about in terms of healing wounds 
to the brain, the facts are now obvious: a major organ of the body is damaged. 
“Treatments” in the DoD and Veterans Administration for a brain-wounded 
population of at least 414,000 post-9/11 veterans typically resolve to rest and “a mix 
of cognitive, physical, speech, and occupational therapy, along with medication to 
control specific symptoms such as headaches or anxiety.” [24] Virtually the last time 
TBI is referred to as a wound is when speaking of “the Invisible Wounds of War.”
Brain wound healing demands that the body grow new tissue: blood vessels, con-
nective tissue, new brain tissue. Cells have to grow and divide to form new tissue, 
necessitating stimulation of cells to divide and multiply. DNA must be stimulated 
[25]. By 2008 DNA analysts found that a single hyperbaric treatment turns on as 
many as 8101 genes in the 24 hours following HBOT treatment [26]. In short, “the 
turned-on genes are those genes that code for growth and repair hormones and the 
anti-inflammatory genes.” [27] As already noted, HBOT is already approved for 
several on-label indications collectively similar as wound healing. It is worth noting 
that HBOT chambers are present in 1158 of a total of 3342 hospitals in the US [28]. 
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Those chambers are primarily used for Wound Healing. For a variety of reasons, 
those chambers are not put to use on off-label uses of HBOT. Nevertheless, the 
bulk of science on animal and human patients with TBI has been collected in both 
hospital-based and private clinics.
Dr. Paul Harch prepared voluminous evidence on HBOT for wound healing in 
his arguments for recognition of DFW in 2002 [29]. More specific to TBI, Dr. Philip 
James, in “Head Injuries – the Curse of Life in the Fast Lane,” [30] traces the devel-
opment of HBOT-for-TBI research as far back as 1972 [31]. The study found that 
tissue oxygen levels that fight hypoxia rise with the increase in either the oxygen 
concentration or pressure: hyperbaric oxygenation. James writes that “this one study 
answers all the questions and objections raised about using hyperbaric oxygen 
treatment for patients with head injury.” [32] Oddo in 2011 identified hypoxia as 
a culprit. Brain hypoxia is associated with poor short-term outcome after severe 
traumatic brain injury independently of elevated ICP, low CPP, and injury sever-
ity. Reduced brain oxygen (Pbto [2]) may be an important therapeutic target after 
severe traumatic brain injury [33]. Dr. Daphne Denham, the nation’s premier expert 
on HBOT treatment of acute concussion, reported that 98% of her patients in her 
Fargo ND clinic [348 out of 350] treated within ten days of suffering a concus-
sion, completely resolved their symptoms in five treatments or less [average of 2.4 
treatments] [34]. The only difference in her patients and the thousands of con-
cussed athletes in North Dakota who linger with symptoms for weeks and months 
using standard of care medicine [AKA “the tincture of time”] was HBOT. [NOTE: 
Maroon and Bost in 2011 write that nonpharmaceutical alternatives, dietary supple-
ments and hyperbaric oxygen “may be a better first-line choice for the treatment 
of PCS, which has generally been underreported by both athletes and the military.” 
[35] Of note for the CMS population is the work of Dr. Anne McKee on the con-
nections between concussion and Chronic Traumatic Encephalopathy (CTE) 
[36]. “CTE is a progressive neurodegeneration clinically associated with memory 
disturbances, behavioral and personality change, Parkinsonism, and speech and 
gait abnormalities.... traumatic injury may interact additively with [Alzheimer’s 
Disease] to produce a mixed pathology with greater clinical impact or synergisti-
cally by promoting pathological cascades that result in either AD or CTE.”
Of no small importance is groundbreaking research from Washington State 
University. Researchers found that HBOT can halve the pain and symptoms of opi-
ate withdrawal/detox [37].
And in current investigations of the use of HBOT to arrest and reverse the 
effects of COVID-19, preliminary evidence from China [38] (five cases) strongly 
suggests that based on the immutable science of HBOT and recent clinical applica-
tion to deteriorating severely hypoxemic COVID-19 pneumonia patients, HBOT has 
significant potential to impact the COVID-19 pandemic. Fifty-eight patients as of 
this writing have been positively affected. Further, clinicians in at least five inde-
pendent studies in the US using HBOT are raising the PO2 levels in patients in ICUs 
to the point where they avoid being put on ventilators and, in many cases, are being 
sent home after as few as five treatments [39].
5. Decades of science: studying HBOT to treat TBI
A review of the scientific evidence produced in both animal and human HBOT 
trials over the past twenty years demonstrates conclusively that Hyperbaric 
Oxygenation of TBI is safe and effective [40]. As early as 1977, Holbach and 
Wasserman demonstrated that HBOT at 1.5ata puts the most oxygen into the brains 
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of chronic stroke patients [41]. The overriding principle of wound healing, of 
course, is that the wound must have energy and oxygen to heal. Hypoxia is the most 
pervasive result of brain insults of all kinds, occasioned by inflammation that leads 
to reduced oxygen delivery to all body organs.
Following a Consensus Conference in 2008, at which it was declared that HBOT 
was safe [42], DoD/Army/VA researchers commenced a series of studies to discern 
whether HBOT was effective in treating TBI. Those studies over nearly eight years 
consumed over $126Million. Other studies in the private sector costing orders of 
magnitude fewer dollars were also conducted. To date, there have been at least 
seventeen peer-reviewed studies that have produced data and findings [43].
U.S. and Israelis clinical trials have provided well-structured, controlled stud-
ies demonstrating HBOT medicinal properties in mild TBI and persistent post-
concussive symptoms [44]. Positive symptom scores for TBI and PTSD symptom 
scores for the two government-sponsored studies [45], the Army-sponsored study 
of Miller et al. [46], a civilian-sponsored study of Harch et al. [47], and an Israeli 
civilian study [48] show statistically significant improvements over baseline after 
HBOT treatments.
The studies involved patients with TBI who also suffered from Persistent Post-
Concussive Syndrome (PPCS) for at least two years. It was highly unlikely that 
spontaneous recovery would occur. Five studies provide useful cross-study compa-
rable measures. The U.S. studies used the Immediate Post-Concussion Assessment, 
Cognitive Testing, Rivermead Post-Concussion Questionnaire, and PTSD 
Checklist–Military (PCL-M) as the primary and secondary endpoint measures. 
Even though the Army/VA/DoD sponsored studies claim to be “sham-controlled,” 
they are really dosing and-pressure- varying trials.
Clinical improvements in the studies were significant and consistent. Looking at 
dose response profiles shows that lower oxygen levels (100% O2) and lower pres-
sures (2.0 ATA) are probably better for PTST/mTBI and PPCS symptom recovery.
Government-sponsored study authors assumed incorrectly that their control 
groups received inactive treatment. Yet they write; “We recognize that a sham is 
not inert, and we cannot completely discount the physiological effects of minimal 
increases in nitrogen or oxygen from pressurized room air. However, we believe it is 
biologically implausible that air at 1.2 ATA (equivalent to 2 m of seawater pressure) 
has a beneficial effect on healing the damaged brain remotely after mTBI [49]. (It 
is worth noting that the comment bears on relationship to the established science 
about the medicinal effects of low levels of either oxygen or pressure.) [50] Positive 
improvements from pretreatment (baseline) measures are observed in all the DoD/
VA/Army and civilian studies. The measured responses to both HBO and HBA treat-
ment groups are therapeutic, but a minimal effective dose of O2 at 1ata pressure has 
not been established in the hyperbaric medical literature. Thus, the use of a sham is 
problematic and confounding for study interpretation.
Deng and his team in a metanalysis evaluated nine studies comparing the effi-
cacy between hyperbaric oxygen treatment and controls in traumatic brain injury 
patients [51]. “Brain metabolism, cognitive function, and outcome were taken 
into consideration. Results showed that HBO treatment significantly improved 
the Glasgow outcome scale (GOS) score and reduced overall mortality in patients 
with severe TBI compared with controls. In patients with mild TBI, HBO showed 
function alleviating the cognitive disorder after trauma, including memory, execu-
tive function, attention, and information processing speed.” In patients with TBI, 
HBO showed significant improvement of Glasgow outcome scale score and reduc-
tion of overall mortality while NBO may play a favorable role in improving brain 
metabolism.
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6. Implications of the science
For over four years, clinical and “evidence-based” medicine continue to show 
that HBOT is safe and effective in treating brain injuries. Objective analysis of 
the data from all the pivotal RCTs and crossover studies show in over 700 patients 
that positive improvements result from HBOT treatment protocols. And objective 
analyses of the studies and data reinforce the findings and the clinical evidence [52].
Dr. Wolf is a principle co-author of the first Army study. This recent USAF paper 
reanalyzing the data in the cornerstone DOD/VA/Army study concludes: “This 
pilot study demonstrated no obvious harm [and] both groups showed improvement 
in scores and thus a benefit. Subgroup analysis of cognitive changes and PCL-M 
results regarding PTSD demonstrated a relative risk of improvement.... There is a 
potential gain and no potential loss. The VA/Clinical Practice Guidelines define a 
“B evidence rating” as “a recommendation that clinicians provide (the service) to 
eligible patients. At least fair evidence was found that the intervention improves 
health outcomes and concludes that benefits outweigh harm .... Hyperbaric oxygen 
therapy for mild traumatic brain injury and PTSD should be considered a legitimate 
adjunct therapy if future studies demonstrate similar findings or show comparable 
improvement to standard-of-care or research-related treatment modalities.” [53] 
Subsequent studies meet those criteria.
The Journal of Hyperbaric Medicine is the most prestigious journal on 
Hyperbaric Medicine in the world. In 2012 its editor wrote: “ While we applaud 
good science, there comes a point.. .. of stagnation as the standard of evidence 
required for the blessing of organized medicine exceeds reality (where most of 
us live.… I feel, as do many of my colleagues, that there is sufficient clinical and 
research evidence to justify the use of [HBOT] as a standard-of-care treatment 
for [TBI] that should be reimbursed by CMS and Tricare…. I have no doubt that, 
over the next several years, [HBOT] will be proven beyond a reasonable doubt to 
be one of the most effective treatments for [TBI]…. There is a preponderance of 
evidence now to justify the use and funding for the treatment….” [54] Wang et al. 
concur: “Compelling evidence suggests the advantage of hyperbaric oxygen therapy 
(HBOT) in traumatic brain injury. ...Patients undergoing hyperbaric therapy 
achieved significant improvement. ... with a lower overall mortality, suggesting its 
utility as a standard intensive care regimen in traumatic brain injury.” [55].
The Samueli Institute wrote of DoD studies: “Results showed that both the 
HBO and sham procedures were associated with significant improvements in 
post-concussion symptoms and secondary outcomes, including PTSD (which most 
participants had), depression, sleep quality, satisfaction with life, and physical, 
cognitive, and mental health functioning.. .. these results are consistent with 2 other 
sham-controlled clinical trials among service members and veterans involving a 
range of HBOT doses. ... The most remarkable lesson of this study was the differ-
ence in clinical outcomes between the 2 chamber procedures (HBO 1.5 ATA and 
‘sham’ air 1.3 ATA) and routine post-concussion care. ... These findings reinforce 
the argument that effective interventions [i.e., the current standard of care prac-
ticed by military medicine] do not yet exist within the present structure of care or 
that routine post-concussion interventions within the [DOD or VHA] may even 
have iatrogenic effects that contribute to symptom persistence, the equivalent of a 
negative placebo (nocebo) effect.” [56].
While this research has been going on, the VA has been quietly conducting a 
controlled “demonstration project” to monitor the effects of HBOT for “PTSD-
only” veterans. For nearly three years, first two and now five sites around the US 
are using HBOT to treat PTSD and TBI patients: Tulsa OK, Travis AFB, Joint Base 
Sam Houston, Tampa, and Fargo ND. While the numbers are small, the results are 
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extremely positive. 30 out of 30 patients have all shown positive medical improve-
ment [57]. Significantly, numerous of the participants are diagnosed with TBI by 
the VA or have been found to have undiagnosed TBI. Either way, the overwhelm-
ing number of patients have improved significantly. These results are significant 
for reasons related to previous attempts to treat PTSD. The National Academies, 
writing in 2014 stated: “DoD and VA are spending substantial time, money, and 
effort on the management of PTSD in service members and veterans [$9.3Billion+ 
through 2014] [yet] neither department knows with certainty whether those many 
programs and services are actually successful in reducing the prevalence of PTSD in 
service members or veterans and in improving their lives.” [58].
A Summary of the positive findings in the studies sponsored by DoD/VA/
Army is instructive. They find that HBOT “offered statistical and in some measures 
clinically significant improvement over local routine TBI care.” They even note 
the improvements in all groups when measured against the no-treatment group. 
Even their “expert” consultants wrote that HBOT heals brain injuries. The Army’s 
premier researcher, Dr. Scott Miller, despite seeming to be looking for “the final nail 
in the coffin” of HBOT, says on the Veterans Affairs web site: “People did get better 
and we can’t ignore those results.” [59].
7. NOTE BENE: the sham and placebo controversies in HBOT
Expert commentary on the issues surrounding the HBOT “sham” revealed the 
fundamental flaws in the DoD/VA/Army research [60]. In a sham treatment, the 
researcher goes through the motions without actually performing the treatment. 
The intent is to have an inert or medically inactive procedure or substance used to 
compare results with active substances. A placebo is often used with half the people 
in a drug trial to help show whether the drug being studied is more effective than 
an inactive “sugar pill.” The results of each group are compared. [NOTE: Debate 
continues on whether it is possible, under the circumstances of HBOT treatment, to 
construct a true sham-controlled study.]
The placebo effect is very difficult, if not impossible, to prove in HBOT studies 
on patients suffering from PPCS that accompanies TBI. Further studies cannot 
ignore a placebo, but the overwhelmingly positive effects in so many, and so widely 
different studies, make the likelihood of a placebo unusual. [NOTE: when physi-
ologic changes, such as both structural and functional increases in brain mass and 
activity are noted – as they were not in DoD/VA/Army studies, since they refuse 
to perform such objective science – it is impossible to ascribe the changes to the 
placebo effect. In numerous of the non-government published peer-reviewed 
studies on the use of HBOT for TBI, however, such positive transformations have 
been noted in the treated patients. Objective evidence of changes are shown in peer-
reviewed research using such methods as SPECT scans, RightEye, qEEG, etc. Those 
changes can only be the effect of exposure to HBOT [61].]
A worldwide surge of challenges arose when the DoD/Army/VA studies pur-
ported to use a sham in their studies and reported that HBOT “does not work.” [62] 
International researchers and authorities could read that both the data and the 
discussion in all the purported randomized controlled studies said virtually the 
same thing: “Both intervention groups [sham and treated] demonstrated improved 
outcomes compared with PCS care alone” [63] Dr. Pierre Marois spoke for many: 
“By definition “sham” is “something false or empty”. Hyperbaric treatments at 1.2 
ATA substantially increase the amount of dissolved oxygen in the blood and simul-
taneously induce cascades of metabolic changes and genes activation. Therefore, the 
supposedly sham treatment of Miller’s study is not close to being a placebo.” [64].
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The clearest example to date that demonstrates that these gas/pressure combina-
tions have a therapeutic effect on brain injury models is the article by Malek et al. 
[65] They demonstrated that HBO (100% O2) and HBA (21% O2/79% N2) were 
equivalent in protecting neurons after transient forebrain ischemia in the gerbil 
using 2.5 ATA. The role of a potential placebo effect was ruled out in this study and 
demonstrates the activity of HBO and HBA in a neurologic injury model.
The certainty that hyperbaric medicine begins with any increase in oxygen 
concentration and/or pressure is further substantiated by on-going work at the 
University of Wisconsin [66]. Animal studies already show a significant increase 
in mobilized stem progenitor cells and decrease in Inflammatory cytokines when 
HBOT and HBAT (room-air) are applied at pressures as low as 1.2ata. Together 
these findings support the likelihood of biologic activity, consubstantial with 
HBOT, being activated at much lower dose of hyperoxia than previously postu-
lated. Those results, coupled with decades of experiments by the US Navy and US 
Air Force [67], demonstrate that the Army’s and UHMS’s claims that hyperbaric 
medicine only occurs at pressures higher than 1.4ata are fallacious. Any increase in 
oxygen concentration and/or pressure is a medical intervention.
The USAF TBI study used the Agency for Healthcare Quality and Research 
recommendations for future HBOT research for TBI. One pertinent comment was 
the following: “Whether placebo-controlled trials are necessary to evaluate HBOT 
has received a great deal of attention in discussions about HBOT. Participants on all 
sides of this debate make the assumption that an “evidence-based” approach implies 
devotion to double-blind, placebo-controlled trials without regard to practical or 
ethical considerations. This assumption is false. Double-blind, placebo-controlled 
trials are the “gold standard” for government regulators overseeing the approval of 
new pharmaceuticals, but not for clinical decision-making or insurance coverage 
decisions. Evidence-based clinical decisions rely more heavily on comparisons of 
one treatment to other potentially effective therapies, not to placebos.” [68].
8. The economic argument in favor of coverage
In what will be a ground-breaking analysis released on Veterans’ Day, November 
11, 2020, The TreatNOW Coalition, building on the seminal work done in 2011 
[69], will update and expand the “true cost of ownership” to the American taxpayer 
of untreated brain injuries. Most studies attempting to estimate costs typically pay 
attention to the obvious cost categories – drugs, yearly health care costs, ER visits, 
hospitalizations, psychiatric care, home health care, long term care, lost wages, 
and sometimes even the impact on the family. TreatNOW has gone much further in 
examining the “ripple effect” through the family and into society.
The Study looks at impact on the family in categories such as physical and 
mental damage to immediate family members, including children and care-givers; 
social services for children affected by turmoil; and spousal suicides occasioned by 
violence and abuse. Divorce, homelessness, drug abuse, incarceration, death-by-
cop, and the estimated 135 people seemingly affected with every suicide [70].
A major “cost” to society beyond the medical expenditures are the tax implica-
tions of taking a brain-wounded citizen out of the work force. In too many cases, 
that actually equates to two lost incomes and taxes because a care-giver is typically a 
full-time aide to the wounded.
Brain Injury Facts about veterans are hard to pin down accurately since there are 
so much missing data. For example, the VA estimates that 70% of veterans are not 
part of the VA system. The VA also estimates TBIs alone for the period of 2000–2017 
is over 414,000. RAND estimates that about one-third of all returning vets reported 
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symptoms of some mental health or cognitive condition. More recent estimates 
range up to 800,000+ for post-9/11, and an equal number of living veterans from 
service in the 20th century. Civilian casualties are estimated by the CDC as 2.5 
million per year, with more than 5 million American effectively unemployable and 
unable to perform activities of daily living.
To summarize a much more robust analytical picture: untreated brain injuries 
cost billions of dollars each year when many of them could be reversed by applica-
tion of HBOT to help heal the underlying and frequently ignored or misdiagnosed 
brain injury. It costs somewhere between $40,000 and $60,000 per year for each 
brain injured patient. HBOT treatment has shown an 85% probability of making 
a significant contribution to the health and welfare of treated patients, at a cost of 
approximately $20,000. Thus, for less than 2% of the costs of sustaining the brain 
wounded on welfare, those brain injuries could be treated. The possibility of return-
ing Quality of life and independence to a significant fraction of those wounded 
is high.
9. Coverage with evidence
Should further research be required before HBOT for TBI receives an indica-
tion, the Center for Medicare and Medicaid (CMS) issued Guidance for the Public, 
Industry, and CMS Staff, Coverage with Evidence Development, November 20, 
2014 [71]. CMS and AHRQ declared that the principal purpose of the study would 
be to test whether the item or service (HBOT for TBI) meaningfully improves 
health outcomes of affected beneficiaries who are represented by the enrolled 
subjects. Unsurprisingly, the data and the demographics support immediate use of 
HBOT.
10. Conclusion
It has been the experience of independent scientists over the last decade that 
peer-reviewed evidence from around the world attests to the safety and efficacy 
of HBOT in treating and helping to heal TBI and other neurological disorders. Yet 
the bulk of research on brain diseases and injury focuses on description and causes 
rather than treatments. Research into “treatments” is by design focused on treating 
symptoms. Clinical Practice Guidelines from the VA/DoD, for example, specifically 
focus on the “management” of concussion/mild traumatic brain injury [72]. Their 
CPG is a compendium of best practices for dealing with symptoms, not with heal-
ing or curing. No mention is made in the document of the wound to the brain, nor 
to healing that wound. And none of the treatments listed as standard of practice are 
approved by the FDA for treating TBI [73].
Unsurprisingly, huge sums are being poured into worldwide research, some 
coordinated, most in a competitive surge to devise better ways to understand the 
structure, function, aberrations and diseases, and treatments for the brain. The 
US (the Brain Initiative), Europe (Human Brain Project), Japan (Brain/MINDS 
Project), China (Brain Project), Israel, Australia and Canada have funded major 
projects [74]. Groups like One Mind and Paul Allen’s Brain Institute are exploring 
how the brain works and what causes neurological disorders. While the projects 
vary slightly in their aims, the thrust is on knowledge rather than clinical medicine 
and healing. Longer-term goals of course include medicine to the patient. Yet pre-
cious little in all the efforts is being done to find immediate-use methods to inter-
vene in areas of wide and profound importance to human mental health.
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On a more mundane basis, federal, state, local, public and private efforts 
continue year-after-year to address in conferences and papers and legislation the 
perennial, interrelated issues of suicide, mental health, brain injury, addiction, 
and neurocognitive and neurological decline. It is hardly surprising that the expen-
ditures promise phenomenal rewards for breakthroughs. Meanwhile, billions are 
expended treating symptoms of underlying brain damage that the science demon-
strates is both treatable and potentially reversible, not later, but now.
Wright and Figueroa summarize for the majority of researchers on the use of 
HBOT to treat and help heal TBI: “There is sufficient evidence for the safety and 
preliminary efficacy data from clinical studies to support the use of HBOT in mild 
traumatic brain injury/persistent post concussive syndrome (mTBI/PPCS). The 
reported positive outcomes and the durability of those outcomes has been demon-
strated at 6 months post HBOT treatment. Given the current policy by Tricare and 
the VA to allow physicians to prescribe drugs or therapies in an off-label manner 
for mTBI/PPCS management and reimburse for the treatment, it is past time that 
HBOT be given the same opportunity. This is now an issue of policy modification 
and reimbursement, not an issue of scientific proof or preliminary clinical effi-
cacy.” [75].
It is time to recognize the worldwide body of data, reduce healthcare costs, 
improve the lives of millions of brain-wounded and their families, and avoid 
lifetimes of lost earnings and the social impact of avoidable suffering. HBOT should 
be endorsed for the treatment of Traumatic Brain Injury. This can be achieved by 
extending CMS coverage to this diagnosis.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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